Bioreductively activated lysyl oxidase inhibitors against hypoxic tumours

ChemMedChem. 2009 Oct;4(10):1590-4. doi: 10.1002/cmdc.200900247.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aminopropionitrile / chemistry
  • Aminopropionitrile / metabolism
  • Aminopropionitrile / pharmacology*
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / metabolism
  • Antineoplastic Agents / pharmacology*
  • Cell Hypoxia / drug effects
  • Cell Line, Tumor
  • Enzyme Inhibitors / chemistry
  • Enzyme Inhibitors / metabolism
  • Enzyme Inhibitors / pharmacology*
  • Humans
  • Hypoxia / enzymology*
  • Neoplasms / enzymology*
  • Oxidation-Reduction
  • Prodrugs / chemistry
  • Prodrugs / metabolism
  • Prodrugs / pharmacology*
  • Protein-Lysine 6-Oxidase / antagonists & inhibitors*

Substances

  • Antineoplastic Agents
  • Enzyme Inhibitors
  • Prodrugs
  • Aminopropionitrile
  • Protein-Lysine 6-Oxidase